Pete, the points that you made and the concerns you have expressed in terms of the apparent lack of meaningful progress over the past eight months with OM and IBD with Brilacidin are certainly valid. What shareholders need at this point, and I believe we deserve, is a shareholders meeting where we would have the opportunity to have a face-to-face Q & A with Leo. (I attended the first and only shareholders meeting in Beverly, Ma six plus years ago) I doubt that it will happen, but it damn well should. I noticed that your post has had more than 200 views without a single response disagreeing with your point of view. I appreciate your post and share your concerns. -- MackG
(4)
(1)
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links